Rafael Holdings, Inc. Class B Common Stock (RFL) Stock Price

RFLStock

$2.24+40.38%52W

Market Cap$116.48M

P/E—

PEG Ratio—

Div yield—

Beta0.23

RFL Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)65.37%

Price vs S&P 500 (4W)1.23%

VGM Score50.51

Book Value / Share (Quarterly)$1.45

P/TBV (Annual)1.41x

Revenue Growth (3Y)30.78%

Cash Flow / Share (Quarterly)$-0.62

Price vs S&P 500 (YTD)73.63%

Gross Margin (TTM)95.10%

Net Profit Margin (TTM)-3321.73%

EPS (TTM)$-0.68

10-Day Avg Trading Volume0.11M

EPS Excl Extra (TTM)$-0.68

Revenue Growth (5Y)-28.51%

EPS (Annual)$-1.02

ROI (Annual)-32.10%

Gross Margin (Annual)85.39%

Net Profit Margin (5Y Avg)-8574.79%

Cash / Share (Quarterly)$0.59

Revenue Growth QoQ (YoY)-50.55%

ROA (Last FY)-26.75%

Revenue Growth TTM (YoY)33.88%

EBITD / Share (TTM)$-0.73

ROE (5Y Avg)-44.04%

Operating Margin (TTM)-3710.31%

Cash Flow / Share (Annual)$-0.36

P/B Ratio1.42x

P/B Ratio (Quarterly)0.88x

Net Income / Employee (Annual)$-1,453,300

EV / Revenue (TTM)78.83x

Net Interest Coverage (TTM)-6.64x

ROA (TTM)-31.70%

EPS Incl Extra (Annual)$-1.02

Current Ratio (Annual)4.89x

Quick Ratio (Quarterly)2.79x

3-Month Avg Trading Volume0.17M

52-Week Price Return40.38%

Revenue / Employee (TTM)$46,700

Tangible BV / Share (Quarterly)$0.83

P/S Ratio (Annual)116.84x

Asset Turnover (Annual)0.01x

52-Week High$3.96

Operating Margin (5Y Avg)-12541.74%

EPS Excl Extra (Annual)$-1.02

CapEx CAGR (5Y)-47.57%

Tangible BV CAGR (5Y)-11.70%

26-Week Price Return76.61%

Quick Ratio (Annual)4.71x

13-Week Price Return64.66%

Total Debt / Equity (Annual)0.01x

Current Ratio (Quarterly)3.16x

Enterprise Value$77.26M

Revenue / Share Growth (5Y)-37.09%

Asset Turnover (TTM)0.01x

Book Value / Share Growth (5Y)-24.57%

Revenue / Employee (Annual)$43,700

Pretax Margin (Annual)-3620.07%

Cash / Share (Annual)$1.01

3-Month Return Std Dev115.37%

Net Income / Employee (TTM)$-1,550,100

ROE (Last FY)-32.33%

Net Interest Coverage (Annual)-1.88x

EPS Basic Excl Extra (Annual)$-1.02

Receivables Turnover (TTM)2.77x

Total Debt / Equity (Quarterly)0.01x

EPS Incl Extra (TTM)$-0.68

Receivables Turnover (Annual)1.74x

ROI (TTM)-38.67%

P/S Ratio (TTM)109.33x

Pretax Margin (5Y Avg)-10874.37%

Revenue / Share (Annual)$0.03

Tangible BV / Share (Annual)$1.18

Price vs S&P 500 (52W)22.07%

Year-to-Date Return85.59%

5-Day Price Return17.74%

EPS Normalized (Annual)$-1.02

ROA (5Y Avg)-37.10%

Net Profit Margin (Annual)-3328.24%

Month-to-Date Return12.89%

Cash Flow / Share (TTM)$-0.36

EBITD / Share (Annual)$-0.97

Operating Margin (Annual)-3179.83%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-40.11%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.68

P/TBV (Quarterly)1.54x

P/B Ratio (Annual)0.92x

Inventory Turnover (TTM)0.17x

Pretax Margin (TTM)-3182.24%

Book Value / Share (Annual)$1.80

Price vs S&P 500 (13W)61.87%

Beta0.23x

Revenue / Share (TTM)$0.02

ROE (TTM)-38.97%

52-Week Low$1.12

vGradeD

gGradeD

mGradeA

vgmGradeC

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
RFLRafael Holdings, Inc. Class B Common Stock	D	D	A	$2.24
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80

About Rafael Holdings, Inc. Class B Common Stock

Rafael Holdings is a biotechnology company with a lead asset, Trappsol Cyclo, in Phase 3 trials for Niemann-Pick Disease Type C1. The company pursues regulatory approval and commercialization while maintaining a diversified portfolio of clinical and early-stage pharmaceutical and medical device investments. Operations span three segments—healthcare, infusion technology, and real estate—with locations in the United States and Israel.